Multicenter, randomized, open-label, phase III trial of decitabine versus patient choice, with physician advice, of either supportive care or low-dose cytarabine for the … HM Kantarjian, XG Thomas, A Dmoszynska, A Wierzbowska, G Mazur, ... Journal of clinical oncology 30 (21), 2670-2677, 2012 | 1290 | 2012 |
Relationship between patients’ knowledge and medication adherence among patients with hypertension B Jankowska-Polańska, I Uchmanowicz, K Dudek, G Mazur Patient preference and adherence, 2437-2447, 2016 | 235 | 2016 |
Insulin resistance and endothelial dysfunction constitute a common therapeutic target in cardiometabolic disorders A Janus, E Szahidewicz-Krupska, G Mazur, A Doroszko Mediators of inflammation 2016 (1), 3634948, 2016 | 229 | 2016 |
The role of chemokines in hypertension. H Martynowicz, A Janus, D Nowacki, G Mazur Advances in clinical and experimental medicine: official organ Wroclaw …, 2014 | 112 | 2014 |
Correlation between sleep bruxism, stress, and depression—a polysomnographic study J Smardz, H Martynowicz, A Wojakowska, M Michalek-Zrabkowska, ... Journal of clinical medicine 8 (9), 1344, 2019 | 99 | 2019 |
The relationship between sleep bruxism and obstructive sleep apnea based on polysomnographic findings H Martynowicz, P Gac, A Brzecka, R Poreba, A Wojakowska, G Mazur, ... Journal of clinical medicine 8 (10), 1653, 2019 | 98 | 2019 |
Genetic basis of sleep bruxism and sleep apnea—response to a medical puzzle M Wieckiewicz, K Bogunia-Kubik, G Mazur, D Danel, J Smardz, ... Scientific reports 10 (1), 7497, 2020 | 94 | 2020 |
The importance of selenium and zinc deficiency in cardiovascular disorders P Gać, K Czerwińska, P Macek, A Jaremków, G Mazur, K Pawlas, ... Environmental toxicology and pharmacology 82, 103553, 2021 | 86 | 2021 |
Resistant Hypertension. A Doroszko, A Janus, E Szahidewicz-Krupska, G Mazur, A Derkacz Advances in clinical and experimental medicine: official organ Wroclaw …, 2016 | 86 | 2016 |
Cognitive deficits and self-care behaviors in elderly adults with heart failure I Uchmanowicz, B Jankowska-Polańska, G Mazur, E Sivarajan Froelicher Clinical Interventions in Aging, 1565-1572, 2017 | 84 | 2017 |
IL-6 and IL-10 promoter gene polymorphisms do not associate with the susceptibility for multiple myeloma G Mazur, K Bogunia-Kubik, T Wróbel, L Karabon, M Polak, K Kuliczkowski, ... Immunology letters 96 (2), 241-246, 2005 | 78 | 2005 |
Sleep bruxism and occurrence of temporomandibular disorders-related pain: a polysomnographic study J Smardz, H Martynowicz, M Michalek-Zrabkowska, A Wojakowska, ... Frontiers in neurology 10, 168, 2019 | 71 | 2019 |
Selected factors affecting adherence in the pharmacological treatment of arterial hypertension B Jankowska-Polańska, A Chudiak, I Uchmanowicz, K Dudek, G Mazur Patient preference and adherence, 363-371, 2017 | 71 | 2017 |
Prognostic significance of Ki-67 antigen expression in non-Hodgkin's lymphomas K Szczuraszek, G Mazur, M JELEŃ, P DZIĘGIEL, P Surowiak, M Zabel Anticancer research 28 (2A), 1113-1118, 2008 | 71 | 2008 |
High soluble transferrin receptor in patients with heart failure: a measure of iron deficiency and a strong predictor of mortality R Sierpinski, K Josiak, T Suchocki, K Wojtas‐Polc, G Mazur, A Butrym, ... European journal of heart failure 23 (6), 919-932, 2021 | 66 | 2021 |
IL-6 and IL-10 promoter gene polymorphisms in psoriasis vulgaris W BArAN, JC SzEPIETOWSkI, G MAzur, E BArAN ACTA DERMATOVENEREOLOGICA-STOCKHOLM- 88 (2), 113, 2008 | 65 | 2008 |
The influence of quality of life on the level of adherence to therapeutic recommendations among elderly hypertensive patients B Uchmanowicz, A Chudiak, G Mazur Patient preference and adherence, 2593-2603, 2018 | 61 | 2018 |
Malnutrition and quality of life in patients with non-small-cell lung cancer J Polański, B Jankowska-Polańska, I Uchmanowicz, M Chabowski, ... Pulmonary Care and Clinical Medicine, 15-26, 2017 | 61 | 2017 |
Thrombocytopenia in pregnancy–pathogenesis and diagnostic approach A Jodkowska, H Martynowicz, B Kaczmarek-Wdowiak, G Mazur Advances in Hygiene and Experimental Medicine 69, 1215-1221, 2015 | 60 | 2015 |
Low expression of microRNA-204 (miR-204) is associated with poor clinical outcome of acute myeloid leukemia (AML) patients A Butrym, J Rybka, D Baczyńska, A Tukiendorf, K Kuliczkowski, G Mazur Journal of Experimental & Clinical Cancer Research 34, 1-5, 2015 | 59 | 2015 |